NetworkNewsBreaks

WednesdayMar 10, 2021 12:26 pm

NetworkNewsBreaks – Life360 Inc. (ASX: 360) to Participate at 33rd Annual ROTH Conference

Life360 (ASX: 360), the leading safety and coordination service for families worldwide, today announced that its CEO Chris Hulls and CFO Russell Burke will participate in the 33rd Annual ROTH Conference scheduled to take place on March 15-17, 2021. Investors will have the opportunity to hear from and meet with executive management from approximately 400 private and public companies in a variety of growth sectors at the event considered a must-attend conference for anyone participating in the small and mid-cap space. According to the update, Life360 management will participate in one-on-one meetings with investors and analysts to discuss 2020 results,…

Continue Reading

WednesdayMar 10, 2021 11:57 am

NetworkNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Partners with Oracle to Offer Oracle CX Suite

iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China and a member of Oracle PartnerNetwork (“OPN”) is working with Oracle to develop a powerful tailored SaaS offering that empowers companies to better serve and connect with consumers in China. Oracle is a leading integrated cloud applications and platform services provider. The collaboration, which will combine the marketing automation capabilities of Oracle Eloqua with iClick's unparalleled data on 940 million Chinese consumers, is designed to address the difficulty international brands have in understanding consumers in China. Ultimately, the partnership will provide integrated SaaS-based solutions that support companies as they identify…

Continue Reading

WednesdayMar 10, 2021 11:50 am

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Collaborates to Advance Commercialization of Patented UST Platform

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life science and other industries, together with the College of Food, Agricultural and Environmental Sciences (“CFAES”) at Ohio State University, recently announced a strategic agreement for the implementation of PBI’s patented Ultra Shear Technology(TM) (“UST”) platform. PBI is developing three different models of the UST processing instrument, named the BaroShear. All three designs, including a small footprint benchtop model, a medium capacity floor model and an industrial scale, continuous flow model for high capacity, are engineered to perform high shear processing of liquids under controlled temperatures…

Continue Reading

WednesdayMar 10, 2021 11:25 am

NetworkNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Empowers Clients with On-Demand Products

InsuraGuest Technologies (TSXV: ISGI) (OTCQB: ISGIF), an innovative insurtech (insurance+technology) company, is engaged in delivering digital insurance to multiple sectors through its proprietary software platform. InsuraGuest harnesses the power of technology to deliver digital offerings across all sectors, empowering clients with on-demand insurance products. A recent article discussing this reads, “The hotels and rental properties who enroll in the InsuraGuest Hospitality Liability coverages require their guests to pay a nominal fee at the time of check-in. InsuraGuest then pays out these small claims, shifting the burden from the hotel operator. With no surge in premium prices, there is no impact…

Continue Reading

WednesdayMar 10, 2021 11:23 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Leverages ‘Absolute Powerhouse Compound’ as IND Status Paves Way for Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco, in a recent podcast, showed his excitement at news that the U.S. Food and Drug Administration (“FDA”) had granted Berubicin investigational new drug (“IND”) status. The IND designation clears the way for the company to start human clinical trials and to ship the experimental drug across state lines to clinical investigators. “This is the biggest news we’ve announced since our IPO back in November 2019,” Climaco said of the significant milestone. “Based on that IND approval, we expect, in the next 90 to 120 days, we will go from zero active clinical trials…

Continue Reading

WednesdayMar 10, 2021 11:09 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Emerging Growth Virtual Conference

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that its CEO James Sapirstein will present at the virtual Maxim Group Emerging Growth Virtual Conference. The two-day conference is slated for March 17–18, 2021. During the online event, all registered attendees will be able to access Sapirstein’s presentation on demand. The presentation will include an overview of AzurRx BioPharma, including its business and clinical-development programs; Sapirstein will also talk about goals and accomplishments the company is working toward in 2021. Following the presentation, Sapirstein and other members of the AzurRx management team will…

Continue Reading

WednesdayMar 10, 2021 10:41 am

NetworkNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) to Host Q4 and Full-Year 2020 Results Conference Call

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, today announced that it will hold a conference call to discuss its results for the four quarter and year ended December 31, 2020. The call, to be hosted by Sigma Labs president and CEO Mark Ruport and CFO Frank Orzechowski, is scheduled to take place at 4:30 p.m. Eastern Time on Wednesday, March 24, 2021, followed by a question-and-answer period. Interested parties can access the call by dialing 1-877-407-9039 (Toll-Free) or 1-201-689-8470 (International) and entering conference ID: 13717059. The conference call will…

Continue Reading

WednesdayMar 10, 2021 10:38 am

NetworkNewsBreaks – Mobius Interactive Inc. Announces Appointment of New VP with Deep Investor Relations, Corporate Development Expertise

Mobius Interactive has appointed a new vice president and board member. Effective immediately Seamus Byrne will take over his new responsibilities, bringing his extensive insight and expertise to bear as he focuses on helping the nascent company achieve its mission. Byrne has more than three decades of capital market experience in both the private and public sectors, gathering a wealth of corporate development knowledge and insight along the way. He has led the development and operations of several different organizations and has played a key role in raising more than C$100 million; he has also driven market capitalizations for public…

Continue Reading

WednesdayMar 10, 2021 10:11 am

NetworkNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Resignation of Outside Director

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, today announced the resignation of John M. Hollister. Hollister served as the company’s CEO prior to its reverse acquisition by Grapefruit Boulevard Investments as well as its transition from a developer of 3D imaging to a fully licensed manufacturer and distributor of cannabis products. These include Grapefruit’s patented, disruptive Hourglass(TM) time-release THC/cannabinoid delivery cream. “We are pleased that the previous chapter of the Imaging3/Grapefruit saga has come to an amicable conclusion. While we, of course, will devote the vast majority of our time and energy to our rapidly growing…

Continue Reading

WednesdayMar 10, 2021 10:00 am

NetworkNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announced Partner Has Received ISO Certification for Rapid COVID-19 Test

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has announced that 3a-diagnostics GmbH ("3a") has received EN ISO 13485 certification for its rapid point-of-care, SARS-CoV-2 RT-PCR Test System ("Covid-ID Lab"). 3a-diagnostics is XPhyto’s exclusive German diagnostics development partner. In addition the company expects CE-IVD approval for the product this month. These two approvals will allow  3a-diagnostics GmbH to distribute the Covid-ID Lab. The EN ISO approval is the internationally recognized European standard for quality control and management systems in the category of design and manufacture of…

Continue Reading